Why publish with us
Why publish your article in Population Medicine?
No Article Processing Charges for non commercial entities
Population Medicine in 2020-2021 does not have author submission or open access fees for authors that are from academic, policy or NGO organisations. Authors affiliated with an industry (i.e. Pharmaceutical industry) submitting their work to Population Medicine are able to retain the copyright of their work for commercial purposes under the Creative Commons Attribution-NoDerivs (CC BY-ND) license (https://creativecommons.org/licenses/by-nd/4.0/). For this commercial Article Processing Charge of 1950 Euros (plus applicable VAT) is applied.

It’s an Open Access journal – you retain copyright
Once accepted and typeset all articles are free to download by all readers without any subscription. Articles published in open access journals are cited more frequently than those in non-open access journals. Furthermore, as all articles are published under the Creative Commons license, you retain ownership and copyright of the article.

Fast and Professional Peer Review -56% rejection rate
We work closely with editors and peer reviewers to provide authors with an efficient, fair, and constructive review process. We offer an easy online submission and peer review process for this purpose. The average time from the date of submission to the first editorial decision is 4 weeks. In 2020, Population Medicine has a rejection rate of 56% - hence ensuring that only articles of merit are published in the journal.

Automated publishing platform
High-quality copy-editing and type-setting guarantee you the best production process. The PDF version of each article is published in a certain format designed to achieve the very best look. Population Medicine uses an advanced, custom-designed, IT publishing platform. Each submitted papers go through the review process and if accepted, a fast track copy editing process.

Participation in the EU Smart Specialisation Strategy RIS3
Journal development has been partially funded through the Smart Specialisation Strategy of Crete, (S3) an innovation policy concept to support regional prioritisation in innovative sectors, fields or technologies. The European Commission introduced the S3 concept in the EU Cohesion Policy 2014-2020 as an ‘ex-ante conditionality’ for European regions to obtain funding for research and innovation from the European Regional Development Fund.

European Publishing is a member of Cross-ref. This citation-linking network covers more than 74 million journal articles, as well as many other content items from a variety of publishers globally. Through Cross-Ref, all articles published in the Population Medicine will receive a unique Digital Object Identification (DOI), that will allow them to be cited by other articles.

For all of these reasons and more, Population Medicine is an excellent journal in which to publish your best papers in the field of public health. Looking forward to receiving your submissions.